SIRION Biotech Teams with CRG to Develop New Generation AAV Vectors
16 Feb 2022 //
BUSINESSWIRE
Sanofi partners with SIRION to improve AAV capsids for gene therapy treatments
24 Feb 2021 //
PHARMA TIMES
SIRION Biotech Licensed Its LentiBOOST™ Transduction Technology to Cellectis
07 Jan 2021 //
BUSINESSWIRE